The Sick State of Banking at RBS
A food company that regularly poisoned people wouldn't expect to stay in business for long. A pharmaceutical company whose drugs made patients sick would be shut down. But a bank that repeatedly rips off its customers? Why, it can just keep paying fines, toss out a "mea culpa" press release, and get back to business as usual -- even when it's 80 percent owned by taxpayers.
To continue reading this article you must be a Bloomberg Professional Service Subscriber.
If you believe that you may have received this message in error please let us know.
- This Tax Bill Is a Trillion-Dollar Blunder
- Thank Goodness for Donald Trump
- 2017 Was Bad for Facebook. 2018 Will Be Worse.
- How Gavin Newsom Got to Be a Front-Runner
- Consider the Consequences of #BelieveAllWomen
- Don't Be Afraid of the Net Neutrality Repeal
- Trump Could Actually Make Democracy Great Again. Don't Scoff.